Home › Research › Disparities
National Trends and Demographic Disparities in Mortality Involving Co-Recorded Parkinson’s Disease and Dementia in the United States, 1999–2025: A CDC WONDER Analysis
Hassaan Abid, Samreen Memon, Vishan Das, Kaneez Fatima, Muhammad Mukhlis, Muhammad Vazaym. NeuroSci, 2026-06-10
Topic: Risk, prevention and care in population studies
Plain-language summary
= 0.002). A sharp transient increase occurred in 2020, attributable to pandemic-related factors including disproportionate COVID-19 mortality among older adults with neurodegenerative conditions, care disruptions, and changes in death-certificate coding practices. Following this pandemic-era peak, AAMRs declined significantly through 2025 and should be interpreted cautiously given provisional data. Males (AAPC: 2.14), non-Hispanic White individuals (AAPC: 2.29), the Midwest region (AAPC: 2.65), and non-metropolitan areas carried the highest mortality burden. Mortality was greatest among adults aged ≥85 years. Population-level death rates involving co-recorded Parkinson's disease and dementia demonstrated significant temporal changes over the study period, with marked demographic and geographic disparities. These findings reflect death-certificate surveillance data and cannot establish clinical co-occurrence, causal relationships, or individual disease risk.
What this study adds
Evidence grade: Low
This analysis of death-certificate data found significant temporal changes and demographic and geographic disparities in mortality involving co-recorded Parkinson's disease and dementia, with a sharp transient increase in 2020. The authors state these surveillance data cannot establish clinical co-occurrence, causal relationships, or individual disease risk, and no treatment, cure, or prevention was tested.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Abid, H., Memon, S., Das, V., Fatima, K., Mukhlis, M., & Vazaym, M. (2026). National Trends and Demographic Disparities in Mortality Involving Co-Recorded Parkinson’s Disease and Dementia in the United States, 1999–2025: A CDC WONDER Analysis. NeuroSci. https://doi.org/10.3390/neurosci7030066
Vancouver
Abid H, Memon S, Das V, Fatima K, Mukhlis M, Vazaym M. National Trends and Demographic Disparities in Mortality Involving Co-Recorded Parkinson’s Disease and Dementia in the United States, 1999–2025: A CDC WONDER Analysis. NeuroSci. 2026. doi:10.3390/neurosci7030066. PMID: 42347154.
BibTeX
@article{abid2026-42347154,
author = {Abid, Hassaan and Memon, Samreen and Das, Vishan and Fatima, Kaneez and Mukhlis, Muhammad and Vazaym, Muhammad},
title = {{National Trends and Demographic Disparities in Mortality Involving Co-Recorded Parkinson’s Disease and Dementia in the United States, 1999–2025: A CDC WONDER Analysis}},
journal = {NeuroSci},
year = {2026},
doi = {10.3390/neurosci7030066},
pmid = {42347154},
url = {https://doi.org/10.3390/neurosci7030066}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- A sharp transient increase occurred in 2020, attributable to pandemic-related factors including disproportionate COVID-19 mortality among older adults with neurodegenerative conditions, care disruptions, and changes in death-certificate coding practices.
- Following this pandemic-era peak, AAMRs declined significantly through 2025 and should be interpreted cautiously given provisional data.
- Males (AAPC: 2.14), non-Hispanic White individuals (AAPC: 2.29), the Midwest region (AAPC: 2.65), and non-metropolitan areas carried the highest mortality burden.
- Mortality was greatest among adults aged ≥85 years.
- Population-level death rates involving co-recorded Parkinson's disease and dementia demonstrated significant temporal changes over the study period, with marked demographic and geographic disparities.
Why it matters
This analysis of death-certificate data found significant temporal changes and demographic and geographic disparities in mortality involving co-recorded Parkinson's disease and dementia, with a sharp transient increase in 2020. The authors state these surveillance data cannot establish clinical co-occurrence, causal relationships, or individual disease risk, and no treatment, cure, or prevention was tested.
New to this subject? Start with our plain-English guide: Disparities →
Study details
- Evidence strengthLow
How this study scored 37/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (NeuroSci) |
| Journal's citation record | 0 / 4 | NeuroSci: journal h-index 20 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 3 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 4 / 6 | Cited 13.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 0 / 4 | Last-listed author Muhammad Vazaym: h-index 1 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Indiana University School of Medicine: institution h-index 784 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42347154) |
| Free to read | 2 / 2 | Free to read |
| Total | 37 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Disparities from nearby years
Also tagged “prevalence”
1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.